Another mammography team in hot water over image quality

The FDA is notifying patients and referrers of another breast-imaging service’s slide into noncompliance with regulatory standards for image quality.

The practice is a mobile unit operated by the Medical University of South Carolina’s Hollings Cancer Center.

Informally referred to as “MUSC Hollings Cancer Center–Mobile,” the unit is presently unaccredited for breast imaging and lacking the certification needed to legally provide mammography services, FDA warned in a notice posted June 30.

The notice says problems at MUSC Hollings Cancer Center–Mobile began in September 2020 when South Carolina’s MQSA inspectors flagged quality control issues during a scheduled visit.

Next, in January 2021, the American College of Radiology notified the state that an additional review had revealed serious deficiencies with the facility’s clinical image quality.

By November 2021, the MUSC mobile unit had successfully completed corrective actions and was granted provisional certification. This allowed it to legally acquire images and so work toward accreditation reinstatement.

However, when the ACR conducted a standardized additional mammography review (AMR) process, the college deemed a number of mammograms again failed to meet ACR quality criteria.

As a result, the facility’s certificate expired on May 10, 2022, FDA reports.

More:

The facility must complete a detailed extensive Corrective Action Plan (CAP) for continued improvement, including additional personnel training and equipment evaluations, before it can submit another accreditation reinstatement application.”

The FDA’s warning on MUSC coincides with a June 30 advisory on Laurel Radiology Services in Laurel, Md.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.